Subgroups | Number of studies | Participants (n) | Heterogeneity test outcomes | Effects model | Meta-analysis | Interaction p-value | |
---|---|---|---|---|---|---|---|
(Experimental/Control) | p-value | I2 (%) | RR (95% CI) | ||||
Intervention | Â | Â | Â | Â | Â | Â | 0.24 |
 LBBF | 333/333 | 0.023 | 68.5% | Random | 0.68 (0.47, 0.99) |  | |
 LBBF +SSC | 304/304 | 0.000 | 90.2% | Random | 0.24 (0.04, 1.31) |  | |
Deliver mode | Â | Â | Â | Â | Â | Â | 0.37 |
 Caesarean | 1 [40] | 100/100 | – | – | Random | 0.32 (0.13, 0.76) |  |
 Vaginal delivery & caesarean | 537/537 | 0.000 | 85.8% | Random | 0.50 (0.30, 0.82) |  | |
Maternal category | Â | Â | Â | Â | Â | Â | 0.37 |
 Primipara | 1 [40] | 100/100 | – | – | Random | 0.32 (0.13, 0.76) |  |
 Primipara & multipara | 537/537 | 0.000 | 85.8% | Random | 0.50 (0.30, 0.82) |  |